Van Eck Associates Corp Becton Dickinson & CO Transaction History

Van Eck Associates Corp

  • $88.3 Billion
  • Q2 2025

A detailed history of Van Eck Associates Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Van Eck Associates Corp holds 1,085 shares of BDX stock, worth $202,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,085
Previous 1,184 8.36%
Holding current value
$202,938
Previous $271,000 31.0%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$165.15 - $226.42 $16,349 - $22,415
-99 Reduced 8.36%
1,085 $187,000
Q1 2025

May 15, 2025
SELL
$222.79 - $249.08 $3.02 Million - $3.38 Million
-13,554 Reduced 91.97%
1,184 $271,000
Q4 2024

Jan 29, 2025
BUY
$220.02 - $243.75 $99,009 - $109,687
450 Added 3.15%
14,738 $3.34 Million
Q3 2024

Oct 29, 2024
BUY
$221.47 - $242.41 $75,078 - $82,176
339 Added 2.43%
14,288 $3.44 Million
Q2 2024

Jul 31, 2024
BUY
$225.07 - $246.17 $161,375 - $176,503
717 Added 5.42%
13,949 $3.26 Million
Q1 2024

Apr 30, 2024
BUY
$233.45 - $247.73 $560,280 - $594,552
2,400 Added 22.16%
13,232 $3.27 Million
Q4 2023

Feb 05, 2024
BUY
$232.24 - $267.23 $78,264 - $90,056
337 Added 3.21%
10,832 $2.64 Million
Q3 2023

Nov 08, 2023
BUY
$254.9 - $283.59 $23,960 - $26,657
94 Added 0.9%
10,495 $2.71 Million
Q2 2023

Aug 03, 2023
SELL
$238.39 - $265.32 $12,157 - $13,531
-51 Reduced 0.49%
10,401 $2.75 Million
Q1 2023

May 03, 2023
BUY
$229.71 - $259.35 $316,999 - $357,903
1,380 Added 15.21%
10,452 $2.59 Million
Q4 2022

Feb 08, 2023
BUY
$218.29 - $256.91 $60,902 - $71,677
279 Added 3.17%
9,072 $2.31 Million
Q3 2022

Oct 27, 2022
BUY
$51.03 - $264.23 $15,053 - $77,947
295 Added 3.47%
8,793 $1.96 Million
Q2 2022

Aug 03, 2022
BUY
$234.74 - $275.42 $76,290 - $89,511
325 Added 3.98%
8,498 $2.1 Million
Q1 2022

May 10, 2022
SELL
$243.64 - $270.48 $86,979 - $96,561
-357 Reduced 4.19%
8,173 $2.17 Million
Q4 2021

Jan 26, 2022
SELL
$230.08 - $250.94 $69,944 - $76,285
-304 Reduced 3.44%
8,530 $2.15 Million
Q3 2021

Nov 03, 2021
SELL
$232.72 - $256.47 $527,110 - $580,904
-2,265 Reduced 20.41%
8,834 $2.17 Million
Q2 2021

Aug 10, 2021
SELL
$232.65 - $254.58 $88,407 - $96,740
-380 Reduced 3.31%
11,099 $2.7 Million
Q1 2021

May 13, 2021
BUY
$232.09 - $256.88 $1.23 Million - $1.36 Million
5,307 Added 85.99%
11,479 $2.79 Million
Q4 2020

Feb 09, 2021
SELL
$221.92 - $245.94 $1,997 - $2,213
-9 Reduced 0.15%
6,172 $1.54 Million
Q3 2020

Nov 12, 2020
SELL
$215.77 - $276.76 $1.84 Million - $2.36 Million
-8,521 Reduced 57.96%
6,181 $1.44 Million
Q2 2020

Aug 10, 2020
SELL
$219.9 - $263.41 $1 Million - $1.2 Million
-4,550 Reduced 23.63%
14,702 $3.52 Million
Q1 2020

May 12, 2020
SELL
$195.69 - $279.01 $566,326 - $807,454
-2,894 Reduced 13.07%
19,252 $4.42 Million
Q4 2019

Feb 13, 2020
BUY
$236.45 - $266.82 $215,405 - $243,073
911 Added 4.29%
22,146 $6.02 Million
Q3 2019

Nov 08, 2019
BUY
$230.58 - $256.08 $157,024 - $174,390
681 Added 3.31%
21,235 $5.37 Million
Q2 2019

Aug 07, 2019
BUY
$217.4 - $246.08 $188,703 - $213,597
868 Added 4.41%
20,554 $5.18 Million
Q1 2019

May 13, 2019
BUY
$206.05 - $248.17 $3.2 Million - $3.85 Million
15,528 Added 373.45%
19,686 $4.92 Million
Q4 2018

Feb 12, 2019
BUY
$204.73 - $257.93 $78,002 - $98,271
381 Added 10.09%
4,158 $937,000
Q3 2018

Nov 13, 2018
BUY
$233.07 - $256.0 $66,658 - $73,216
286 Added 8.19%
3,777 $986,000
Q2 2018

Aug 13, 2018
BUY
$208.1 - $233.85 $688,602 - $773,809
3,309 Added 1818.13%
3,491 $836,000
Q1 2018

May 11, 2018
BUY
$205.46 - $240.27 $37,393 - $43,729
182 New
182 $39,000

Others Institutions Holding BDX

# of Institutions
1,756
Shares Held
259M
Call Options Held
1.82M
Put Options Held
696K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $53.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email